Showing posts with label Covidien. Show all posts
Showing posts with label Covidien. Show all posts

Wednesday, August 31, 2011

Tiffany (TIF) (AOSL) (CF) (SCHW) (COV) (ESRX) Price Targets Changed

Tiffany & Co. (NYSE: TIF), Alpha and Omega Semi (NASDAQ: AOSL), CF Industries Holdings Inc. (NYSE: CF), Charles Schwab (NASDAQ: SCHW), Covidien plc (NYSE: COV) and Express Scripts, Inc. (NASDAQ: ESRX) had price targets adjusted by analysts.

Tiffany & Co. (TIF) had its price target raised by Deutsche Bank (NYSE:DB) from $76.00 to $79.00. They have a “Hold” rating on the company.

Alpha and Omega Semi (AOSL) had its price target lowered by Deutsche Bank (NYSE:DB) from $13.00 to $10.00. They have a “Hold” rating on the company.

CF Industries Holdings Inc. (CF) had its price target raised by Feltl & Co. from $211.00 to $218.25. They have a “Strong Buy” rating on the company.

Charles Schwab (SCHW) had its price target lowered by Stifel Nicolaus from $21.00 to $15.00. They have a “Buy” rating on the company.

Covidien (COV) had its price target raised by Goldman Sachs (NYSE:GS)to $60.00. They have a “Buy” rating on the company.

Express Scripts, Inc. (ESRX) had its price target lowered by JMP Securities to $69.00. They have an “Outperform” rating on the company.

Tuesday, August 30, 2011

Nokia (NOK) (COV) (CVS) (DCI) (ESRX) EPS Estimates Changed

Nokia (NYSE:NOK), Covidien (NYSE:COV), CVS Caremark (NYSE:CVS), Donaldson (NYSE:DCI) and Express Scripts (NASDAQ:ESRX) had their EPS estimates adjusted by analysts.

Nokia (NOK) EPS estimates were raised by Oppenheimer through 2012. They have a "Market Perform" rating on the company.

Covidien (COV) had its EPS estimates raised by Goldman Sachs (NYSE:GS). They have a price target of $60 and a "Buy" rating on the company.

CVS Caremark (CVS) EPS estimates were increased through 2012 by JMP Securities. They have a "Market Outperform" rating on the company.

Donaldson (DCI) EPS estimates were boosted through 2013 by Credit Suisse (NYSE:CS). They have a price target of $67 and an "Outperform" rating on the company.

Express Scripts (ESRX) EPS estimates were lowered by JMP Securities. They also cut their price target to $69, and have a "Market Perform" rating on the company.

Wednesday, August 17, 2011

Lowe’s (LOW) (RIMM) (CMA) (COV) (DRC) (QRE) Price Targets Changed

Lowe’s (NYSE: LOW), Research In Motion (NASDAQ: RIMM), Comerica (NYSE: CMA), Covidien Plc (NYSE: COV), Dresser-Rand (NYSE: DRC) and QR Energy LP (NYSE: QRE) price targets adjusted by analysts.

Research In Motion (RIMM) had its price target boosted by Sterne Agee to $28.00. They have a “Neutral” rating on the company.

Comerica (CMA) had its price target lowered by Sterne Agee to $35.00. They have a “Buy” rating on the company.

QR Energy LP (QRE) had its price target lowered by Oppenheimer to $23.00.

Covidien Plc (COV) had its price target raised by Morgan Keegan from $56.00 to $60.00. They have an “Outperform” rating on the company.

Lowe’s (LOW) had its price target lowered by Piper Jaffray (NYSE:PJC)to $19.00. They have a “Neutral” rating on the company.

Dresser-Rand (DRC) had its price target lowered by Morgan Keegan from $63.00 to $52.50. They have an “Outperform” rating on the company.

Wednesday, May 18, 2011

Price Targets on (CWCO) (COST) (COV) (CSCO) (CSIQ) Updated

Price targets on Consolidated Water Co. Ltd. (NASDAQ: CWCO), Costco (NASDAQ: COST), Covidien plc (NYSE: COV), Cisco Systems, Inc. (NASDAQ: CSCO) and Canadian Solar Inc. (NASDAQ: CSIQ) shares of updated by analysts.

Brean Murray raised their price target on Consolidated Water Co. Ltd. (CWCO) from $12.00 to $13.00. They have a “buy” rating on the company.

Jefferies (NYSE:JEF) raised their price target on Costco (COST) from $85.00 to $93.00. They have a “buy” rating on the company.

Morgan Stanley (NYSE:MS) raised their price target on Covidien plc (COV) from $60.00 to $63.00. They have an “overweight” rating on the company.

Wedbush cut their price target on Cisco Systems, Inc. (CSCO) from $22.00 to $21.00.

Jefferies cut their price target on Canadian Solar Inc. (CSIQ) from $15.00 to $14.00. They have a “buy” rating on the company.

Monday, May 2, 2011

Dividend Yields for (AET) (COV) (PDCO) (HUM) (WLP)

Indicated dividend yields for Standard & Poor's 500 Index companies Aetna Inc (AET), Covidien PLC (COV), Patterson Cos Inc (PDCO), Humana Inc (HUM) and WellPoint Inc (WLP).

These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.

Aetna Inc (AET) has a dividend yield of 1.45 percent on a declared dividend of $0.15. The payout ratio is 9.8 percent.

Covidien PLC (COV) has a dividend yield of 1.44 percent on a declared dividend of $0.20. The payout ratio is 22.9 percent.

Patterson Cos Inc (PDCO) has a dividend yield of 1.38 percent on a declared dividend of $0.12. The payout ratio is 21.3 percent.

Humana Inc (HUM) has a dividend yield of 1.31 percent on a declared dividend of $0.25. The payout ratio is na.

WellPoint Inc (WLP) has a dividend yield of 1.30 percent on a declared dividend of $0.25. The payout ratio is 10.1 percent.

Tuesday, February 1, 2011

Masimo (Nasdaq:MASI) Shares Soar on Covidien (NYSE:COV) Royalty Extension

News that Masimo (Nasdaq:MASI) had extended its royalty agreement with Covidien PLC (NYSE:COV) resulted in shares of the company soaring.

The extension will be for three years, and include a royalty payment from Covidien to Masimo of 7.75 percent for American sales of its pulse-oximetry products.

Pulse-oximetry devices monitor the pulse rates and oxygen saturation levels in the blood of patients.

Masimo closed Monday at $29.98, gaining $2.40, or 8.68 percent. Covidien closed at $47.47, gaining $0.39, or 0.83 percent.

Tuesday, January 4, 2011

JPMorgan (NYSE:JPM) MedTech Favorites Include St. Jude (NYSE:STJ), Covidien (NYSE:COV), Insulet (Nasdaq:PODD), BioMimetic Therapeutics (Nasdaq:BMTI)

JPMorgan (NYSE:JPM) gave their 2011 outlook on numerous companies within the MedTech sector today, with their favorites being St. Jude (NYSE:STJ), Covidien (NYSE:COV), Insulet (Nasdaq:PODD) and BioMimetic Therapeutics (Nasdaq:BMTI)

Those companies with the sector JPMorgan expects to outperform include Becton, Dickinson and Company (NYSE:BDX), Stryker (NYSE:SYK), Varian Medical (NYSE:VAR), Edwards Lifesciences (NYSE:EW), Nxstage Medical (Nasdaq:NXTM), Hologic (Nasdaq:HOLX), Heartware (Nasdaq:HTWR), Volcano (Nasdaq:VOLC) and SonoSite (Nasdaq:SONO).

MedTech companies viewed with downside by JPMorgan are Intuitive Surgical (Nasdaq:ISRG), Boston Scientific (NYSE:BSX), Medtronic (NYSE:MDT), Wright Medical Group (Nasdaq:WMGI), CareFusion (NYSE:CFN), Thoratec (Nasdaq:THOR) NuVasive (Nasdaq:NUVA), Mako Surgical (Nasdaq:MAKO) and American Medical Systems (Nasdaq:AMMD).

St. Jude closed Tuesday at $42.28, losing $0.47, or 1.10 percent. Covidien closed at $47.45, gaining $1.79, or 3.92 percent. Insulet ended the day at $16.07, up $0.57, or 3.68 percent. BioMimetic Therapeutics closed at $13.46, up $0.76, or 5.98 percent.